BCAM-Basque Center for Applied Mathematics, Alameda Mazarredo 14, Bilbao, Basque Country, 48009, Spain.
Preventive Medicine and Public Health Department, University of the Basque Country (UPV/EHU), Leioa, Basque Country, Spain.
J Epidemiol Glob Health. 2024 Sep;14(3):1289-1299. doi: 10.1007/s44197-024-00286-6. Epub 2024 Aug 26.
COVID-19 vaccines have demonstrated significant efficacy in reducing severe symptoms and fatalities, although their effectiveness in preventing transmission varies depending on the population's age profile and the dominant variant. This study evaluates the impact of the COVID-19 vaccination campaign in the Basque Country region of Spain, which has the fourth highest proportion of elderly individuals worldwide. Using epidemiological data on hospitalizations, ICU admissions, fatalities, and vaccination coverage, we calibrated four versions of an ordinary differential equations model with varying assumptions on the age structure and transmission function. Counterfactual no-vaccine scenarios were simulated by setting the vaccination rate to zero while all other parameters were held constant. The initial vaccination rollout is estimated to have prevented 46,000 to 75,000 hospitalizations, 6,000 to 11,000 ICU admissions, and 15,000 to 24,000 deaths, reducing these outcomes by 73-86%. The most significant impact occurred during the third quarter of 2021, coinciding with the Delta variant's dominance and a vaccination rate exceeding 60%. Sensitivity analysis revealed that vaccination coverage had a more substantial effect on averted outcomes than vaccine efficacy. Overall, the vaccination campaign in the Basque Country significantly reduced severe COVID-19 outcomes, aligning with global estimates and demonstrating robustness across different modeling approaches.
COVID-19 疫苗在降低重症症状和死亡率方面表现出显著的效果,但其在预防传播方面的效果因人群的年龄结构和主要变异株而异。本研究评估了 COVID-19 疫苗接种运动在西班牙巴斯克地区的影响,该地区是全球老年人比例第四高的地区。利用关于住院、重症监护病房(ICU)入院、死亡和疫苗接种覆盖率的流行病学数据,我们使用了四个不同的常微分方程模型版本,这些模型对年龄结构和传播函数的假设不同。通过将疫苗接种率设置为零,同时保持所有其他参数不变,模拟了没有疫苗的反事实情况。初步的疫苗接种推出估计预防了 46000 至 75000 例住院、6000 至 11000 例 ICU 入院和 15000 至 24000 例死亡,将这些结果降低了 73-86%。最大的影响发生在 2021 年第三季度,恰逢 Delta 变异株的主导地位和疫苗接种率超过 60%。敏感性分析表明,疫苗接种覆盖率对避免的结果的影响比疫苗效力更大。总体而言,巴斯克地区的疫苗接种运动显著降低了严重 COVID-19 的结果,与全球估计一致,并在不同的建模方法中表现出稳健性。